These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16312364)

  • 21. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thuggacins, novel antibacterial macrolides from Sorangium cellulosum acting against selected Gram-positive bacteria.
    Irschik H; Reichenbach H; Höfle G; Jansen R
    J Antibiot (Tokyo); 2007 Dec; 60(12):733-8. PubMed ID: 18276996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
    Zientara M; Rudy M; Nowakowska M; Martirosian G
    Med Dosw Mikrobiol; 2006; 58(3):239-45. PubMed ID: 17340999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On a simple method for freeing pathological materials from fungi for the purpose of making bacterial antibiograms].
    Scoles E; Sisti F
    Rass Int Clin Ter; 1966 Dec; 46(24):1341-2. PubMed ID: 4872444
    [No Abstract]   [Full Text] [Related]  

  • 26. C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.
    Poce G; Cesare Porretta G; Biava M
    Expert Opin Ther Pat; 2009 Jun; 19(6):901-6. PubMed ID: 19473109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial resistance pattern among aerobic gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre.
    Kumari HB; Nagarathna S; Chandramuki A
    Indian J Chest Dis Allied Sci; 2007; 49(1):19-22. PubMed ID: 17256562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
    Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004].
    Lemort ML; Neuville S; Medus M; Gueudet P; Saada M; Aumaître H; Lecaillon E
    Pathol Biol (Paris); 2006; 54(8-9):427-30. PubMed ID: 17027183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults.
    File TM
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S131-4. PubMed ID: 18029151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel azalides derived from sixteen-membered macrolides.
    Miura T; Natsume S; Kanemoto K; Atsumi K; Fushimi H; Sasai H; Arai T; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2007 Jul; 60(7):407-35. PubMed ID: 17721001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
    Biedenbach DJ; Jones RN; Fritsche TR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):240-4. PubMed ID: 18353594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and characterization of bacterial strains in subjects hospitalized in a pediatric intensive care unit].
    Orefici G; Scopetti F; Occhionero M; Biondi F
    Ann Ist Super Sanita; 1981; 17(4):819-30. PubMed ID: 7347141
    [No Abstract]   [Full Text] [Related]  

  • 34. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005.
    Wagenlehner FM; Niemetz AH; Weidner W; Naber KG
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S25-34. PubMed ID: 17997282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic synergy testing should not be routine for patients with cystic fibrosis who are infected with multiresistant bacterial organisms.
    Aaron SD
    Paediatr Respir Rev; 2007 Sep; 8(3):256-61. PubMed ID: 17868924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility patterns of respiratory tract pathogens from sheep and goats.
    Berge AC; Sischo WM; Craigmill AL
    J Am Vet Med Assoc; 2006 Oct; 229(8):1279-81. PubMed ID: 17042733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infectivity and resistance to antibiotics of bacterial strains isolated from patients hospitalised in intensive care units].
    Wojnicz D; Korzekwa K; Kakol A; Doroszkiewicz W
    Med Dosw Mikrobiol; 2007; 59(1):75-84. PubMed ID: 17601034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and susceptibility of pathogenic bacteria responsible for upper respiratory tract infections in pet rabbits.
    Rougier S; Galland D; Boucher S; Boussarie D; Vallé M
    Vet Microbiol; 2006 Jun; 115(1-3):192-8. PubMed ID: 16530989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.